Screener
Phathom Pharmaceuticals, Inc. PHAT Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Phathom Pharmaceuticals, Inc.’s reported figures.
The source filing: Phathom Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 7:05 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-324867
FAQ
- What is Phathom Pharmaceuticals, Inc.'s free cash flow?
- Phathom Pharmaceuticals, Inc. (PHAT) reported free cash flow of -$1.97M in Q2 2026.
- How has Phathom Pharmaceuticals, Inc.'s free cash flow changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s free cash flow increased by 96.9% year-over-year, from -$62.83M to -$1.97M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s free cash flow?
- Over 4 years (2021 to 2025), Phathom Pharmaceuticals, Inc.'s free cash flow has grown at a 2.9% compound annual growth rate (CAGR), from -$148.95M to -$167M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Phathom Pharmaceuticals, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude